A role for nebulized tranexamic acid in veno-venous ECMO patients.

Maria Gabriela CabanillaNicholas E VillalobosShozab Ahmed

Published in: Journal of clinical pharmacy and therapeutics (2021)

This series demonstrates successful bleeding management with nebulized tranexamic acid, reducing the frequency of ECMO circuit changes, time off of anticoagulation and blood loss.

Keyphrases

extracorporeal membrane oxygenation
end stage renal disease
acute respiratory distress syndrome
atrial fibrillation
newly diagnosed
ejection fraction
chronic kidney disease
venous thromboembolism
peritoneal dialysis
respiratory failure